prof. dr. H.J.H.M. Claassen

prof. dr.

20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

European General Practitioners perceptions on probiotics: Results of a multinational survey

van der Geest, A. M., Flach, J., Claassen, E., Sijlmans, A. W., van de Burgwal, L. H. M. & Larsen, O. F. A., 1 Mar 2020, In : PharmaNutrition. 11, p. 1-5 5 p., 100178.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access
2019

Aiming for impact: Differential effect of motivational drivers on effort and performance in knowledge valorisation

Van De Burgwal, L. H. M., Hendrikse, R. & Claassen, E., Oct 2019, In : Science and Public Policy. 46, 5, p. 747-762 16 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Dealing with the remaining controversies of probiotic safety

Van Den Nieuwboer, M. & Claassen, E., Jun 2019, In : Beneficial Microbes. 10, 6, p. 605-616 12 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Policies and patenting to stimulate the biotechnology sector: Evidence from the Netherlands

Van Dongen, P., Tak, H. & Claassen, E., 1 Feb 2019, In : Science and Public Policy. 46, 1, p. 136-147 12 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Probiotics for Childhood Functional Gastrointestinal Disorders: Do We Know What We Advise?

Browne, P. D., de Groen, A. C., Claassen, E. & Benninga, M. A., 1 Dec 2019, In : PharmaNutrition. 10, p. 1-7 7 p., 100160.

Research output: Contribution to JournalArticleAcademicpeer-review

Probiotics for improving quality of life in ulcerative colitis: Exploring the patient perspective

van der Waal, M. B., Flach, J., Browne, P. D., Besseling-van der Vaart, I., Claassen, E. & van de Burgwal, L. H. M., Mar 2019, In : PharmaNutrition. 7, p. 1-14 14 p., 100139.

Research output: Contribution to JournalArticleAcademicpeer-review

Probiotics in pregnancy: Protocol of a double-blind randomized controlled pilot trial for pregnant women with depression and anxiety (PIP pilot trial)

Browne, P. D., Bolte, A., Claassen, E. & De Weerth, C., 17 Jul 2019, In : Trials. 20, p. 1-21 21 p., 440.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access
Open Access

The Nagoya Protocol on Access to Genetic Resources and Benefit Sharing: Best practices for users of Lactic Acid Bacteria

Flach, J., dos S. Ribeiro, C., van der Waal, M. B., van der Waal, R. X., Claassen, E. & van de Burgwal, L. H. M., Sep 2019, In : PharmaNutrition. 9, p. 1-6 6 p., 100158.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Towards a rational design of faecal transplant analogues

Larsen, O. F. A., Koning, A. H. J., van der Spek, P. J. & Claassen, E., 3 Apr 2019, In : Scientific Reports. 9, p. 1-6 6 p., 5558.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access
2018

A research agenda to reinforce rabies control: A qualitative and quantitative prioritization

Neevel, A. M. G., Hemrika, T., Claassen, E. & van de Burgwal, L. H. M., 4 May 2018, In : PLoS Neglected Tropical Diseases. 12, 5, e0006387.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Economic potential of probiotic supplementation in institutionalized elderly with chronic constipation

Flach, J., Koks, M., van der Waal, M. B., Claassen, E. & Larsen, O. F. A., Dec 2018, In : PharmaNutrition. 6, 4, p. 198-206 9 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

How ownership rights over microorganisms affect infectious disease control and innovation: A root-cause analysis of barriers to data sharing as experienced by key stakeholders

Ribeiro, C. D. S., van Roode, M. Y., Haringhuizen, G. B., Koopmans, M. P., Claassen, E. & van de Burgwal, L. H. M., 2 May 2018, In : PLoS ONE. 13, 5, e0195885.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Hybrid business models for ‘Organ-on-a-Chip’ technology: The best of both worlds

van de Burgwal, L. H. M., van Dorst, P., Viëtor, H., Luttge, R. & Claassen, E., Jun 2018, In : PharmaNutrition. 6, 2, p. 55-63 9 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Probiotic research priorities for the healthy adult population: A review on the health benefits of Lactobacillus rhamnosus GG and Bifidobacterium animalis subspecies lactis BB-12

Flach, J., van der Waal, M. B., Kardinaal, A. F. M., Schloesser, J., Ruijschop, R. M. A. J. & Claassen, E., 16 Mar 2018, In : Cogent Food & Agriculture. 4, p. 1-30 30 p., 1452839.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access
Open Access
2017

Analysing patent terms and citations to determine the value of gene therapies

van Dongen, P., El Hejazi, Z. N. & Claassen, H. J. H. M., 1 Apr 2017, In : Journal of Commercial Biotechnology. 23, 2, p. 61-73 13 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Barriers to innovation in human rabies prophylaxis and treatment: A causal analysis of insights from key opinion leaders and literature.

van de Burgwal, L. H. M., Neevel, A. M. G., Pittens, C. A. C. M., Osterhaus, A. D. M. E., Rupprecht, C. E. & Claassen, H. J. H. M., 1 Dec 2017, In : Zoonoses and Public Health. 64, 8, p. 599-611 13 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Challenges and best practices for big data-driven healthcare innovations conducted by profit–non-profit partnerships – a quantitative prioritization

Witjas-Paalberends, E. R., van Laarhoven, L. P. M., van de Burgwal, L. H. M., Feilzer, J., de Swart, J., Claassen, H. J. H. M. & Jansen, W. T. M., 6 Sep 2017, In : International Journal of Healthcare Management. 11, 3, p. 1-11 11 p., http://dx.doi.org/10.1080/20479700.2017.1371367.

Research output: Contribution to JournalArticleAcademicpeer-review

Incentives for knowledge valorisation: a European benchmark

van de Burgwal, L. HM., Dias, A. & Claassen, H. J. H. M., Jun 2017, In : The Journal of Technology Transfer. 44, 1, p. 1-20 20 p., DOI: 10.1007/s10961-017-9594-8.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Medical doctors’ perceptions on probiotics: Lack of efficacy data hampers innovation

Flach, J., Dias, A. S. M., Rademaker, S. H. M., van der Waal, M. B., Claassen, E. & Larsen, O. F. A., 27 Jun 2017, In : PharmaNutrition. 2017, 5, p. 103-108 6 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Probiotics for healthy ageing: Innovation barriers and opportunities for bowel habit improvement in nursing homes

Larsen, O. F. A., van den Nieuwboer, M., Koks, M., Flach, J. & Claassen, H. J. H. M., 2017, In : Agro FOOD Industry Hi Tech. 28, 5, p. 12-15 4 p.

Research output: Contribution to JournalArticleAcademicpeer-review

The mechanistic link between health and gut microbiota diversity

Claassen, H. J. H. M. & Larsen, O. F. A., 2017, (Accepted/In press) In : Scientific Reports. 8, 1, p. 1-5 5 p., 2183.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance

Fernald, K. D. S., Pennings, H. P. G., van den Bosch, J. F., Commandeur, H. R. & Claassen, H. J. H. M., 23 Feb 2017, In : PLoS ONE. 12, 2, p. e0172488 e0172488.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

The relationships between university IP regimes, scientists’ motivations and their engagement with research commercialisation in Europe

van Dongen, P., Yegros, A., Tijssen, R. & Claassen, H. J. H. M., 2017, In : European Journal of Law and Technology. 8, 2, p. 1-22 22 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access
2016
Open Access

Lactobacillus plantarum WCFS1 and its host interaction: a dozen years after the genome

van den Nieuwboer, M., van Hemert, S., Claassen, E. & de vos, W., Jul 2016, In : Microbial Biotechnology. 9, 4, p. 452-65 14 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Self-Centric and Altruistic Unmet Needs for Ebola: Barriers to International Preparedness

Van de Burgwal, L. H. M., Reperant, L. A., Osterhaus, A. D. M. E., Iancu, S. C., Pronker, E. S. & Claassen, H. J. H. M., 20 Jun 2016, In : Disaster medicine and public health preparedness. 10, 4, p. 644-8 5 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Vector-based genetically modified vaccines: Exploiting Jenner's legacy

Ramezanpour, B., Haan, I., Osterhaus, A. & Claassen, E., 7 Dec 2016, In : Vaccine. 34, 50, p. 6436-6448 13 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Venturing across the Atlantic

Rooswinkel, R. W., Berbers, D. S. W., Claassen, E. H. J. H. M. & van Deventer, S., 8 Nov 2016, In : Nature Biotechnology. 34, 11, p. 1095-1098 4 p.

Research output: Contribution to JournalArticleAcademicpeer-review

2015

An interdisciplinairy analysis of genetically modified vaccines: from clinical trials to market.

Ramezanpour, B., Riemens, T., van de Burgwal, L. H. M. & Claassen, E., 2015, In : International Journal of Clinical Trials. 2, 4, p. 64-74

Research output: Contribution to JournalArticleAcademicpeer-review

A quantitative key-opinion-leader analysis of innovation barriers in probiotic research and development: valorisation and improving the tech transfer cycle

van den Nieuwboer, M., van de Burgwal, L. H. M. & Claassen, E., 2015, In : PharmaNutrition. 4, 1, p. 9-18 9 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Biotechnology Commercialization Strategies: Risk and Return in Interfirm Cooperation

Fernald, K. D. S., Pennings, H. P. G. & Claassen, E., Nov 2015, In : Journal of Product Innovation Management. 32, 6, p. 971-996 26 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Cost-effectiveness in Clostridium difficile treatment decision-making.

Nuijten, M. J., Keller, J. J., Visser, C. E., Redekop, K., Claassen, E., Speelman, P. & Pronk, M. H., 2015, In : World journal of clinical cases. 3, 11, p. 935-941

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Improving the bowel habits of elderly residents in a nursing home using probiotic fermented milk

van den Nieuwboer, M., Klomp-Hogeterp, A., Verdoorn, S., Metsemaker-Brameijer, L., Vriend, T. M., Claassen, E. & Larsen, O. F. A., 2015, In : Beneficial Microbes. 6, p. 397-403

Research output: Contribution to JournalArticleAcademicpeer-review

Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis.

Ramezanpour, B., Pronker, E. S., Kreijtz, J. H. C. M., Osterhaus, A. D. M. E. & Claassen, E., 2015, In : Vaccine. 33, 35, p. 3349-3358

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Patient needs and research priorities in probiotics: A quantitative KOL prioritization analysis with emphasis on infants and children

van den Nieuwboer, M., Browne, P. D. & Claassen, E., 2015, In : PharmaNutrition. 4, 1, p. 19-28 9 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Safety of probiotics and synbiotics in children under 18 years of age.

van den Nieuwboer, M., Brummer, R. J., Guarnar, F., Morelli, L., Cabana, M. & Claassen, E., 2015, In : Beneficial Microbes. 6, 5, p. 615-630

Research output: Contribution to JournalArticleAcademicpeer-review

Scratching the surface: Exploratory analysis of key opinion leaders on rate limiting factors in novel adjuvanted-vaccine

Pronker, E. S., Claassen, E., Weenen, T., Commandeur, H. & Osterhaus, A. D. M. E., 2015, In : Technological Forecasting and Social Change. 90, B, p. 420-432

Research output: Contribution to JournalArticleAcademicpeer-review

Trade-sale exits in different biotech sectors

Fernald, K. D. S. & Claassen, E., 2015, In : Nature Biotechnology. 33, p. 1221-1239

Research output: Contribution to JournalArticleAcademicpeer-review

Venture capitalists as gatekeepers for biotechnological innovation

Fernald, K., Hoeben, R. & Claassen, H. J. H. M., 1 Jul 2015, In : Journal of Commercial Biotechnology. 21, 3, p. 32-41 10 p.

Research output: Contribution to JournalArticleAcademicpeer-review

2014

A critical look at medical nutrition terminology and definitions,

Claassen, E., Weenen, T. C. & Commandeur, H., 2014, In : Trends In Food Science & Technology. 38, 1, p. 34-46

Research output: Contribution to JournalArticleAcademicpeer-review

Adopting Health Apps, What’s Hindering Doctors and Patients?

Dehzad, F., Hilhorst, C., de Bie, C. & Claassen, E., 2014, In : Health (London). 6, p. 2204-2217

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Cost-benefit relation of diet and probiotics in iatrogenic bowel irregularity

Claassen, E., 2014, In : Frontiers in Pharmacology. 5, 14.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Ebola: public-private partnerships

Reperant, L. A., van de Burgwal, L. H. M., Claassen, E. & Osterhaus, A. D. M. E., 2014, In : Science. 346, p. 433-434 6208.

Research output: Contribution to JournalArticleAcademicpeer-review

Patient needs and research priorities in the enteral nutrition market - A quantitative prioritization analysis.

Weenen, T. C., Jentink, A. W., Pronker, E. S., Commandeur, H. R., Claassen, E., Boirie, Y. & Singer, P., 2014, (Accepted/In press) In : Clinical Nutrition. 33, 5, p. 793-801

Research output: Contribution to JournalArticleAcademicpeer-review

The administration of Probiotics and Synbiotics in Immune Compromised Adults: is it Safe?

van den Nieuwboer, M., Brummer, R. J., Guarner, F., Morelli, L. & Claassen, E., 2014, (Accepted/In press) In : Beneficial Microbes.

Research output: Contribution to JournalArticleAcademicpeer-review

2013

A decision framework to evaluate intellectual property strategies in the medical nutrition market.

Weenen, T. C., Jentink, A. W., Pronker, E. S., Commandeur, H. R. & Claassen, E., 2013, In : PharmaNutrition. 1, 2, p. 65-72

Research output: Contribution to JournalArticleAcademicpeer-review

Food-Pharma Convergence in Medical Nutrition - Best of Both Worlds?

Weenen, T. C., Ramezanpour, B., Pronker, E. S., Commandeur, H. R. & Claassen, E., 2013, In : PLoS ONE. 8, 12

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Limits of Biotechnological Innovation

Fernald, K. D. S., Weenen, T. C., Sibley, K. J. & Claassen, E., 2013, In : Technology and Investment. 2013, 4, p. 168-178 10 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access